Coltri Kely C, Oliveira Leandro L, Pinzan Camila F, Vendruscolo Patrícia E, Martinez Roberto, Goldman Maria Helena, Panunto-Castelo Ademilson, Roque-Barreira Maria-Cristina
Departamento de Biologia Celular e Molecular e Bioagentes Patogênicos, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 14049-900-Ribeirão Preto, São Paulo, Brazil.
Am J Pathol. 2008 Aug;173(2):423-32. doi: 10.2353/ajpath.2008.080126. Epub 2008 Jul 3.
KM(+) is a mannose-binding lectin from Artocarpus integrifolia that induces interleukin (IL)-12 production by macrophages and protective T helper 1 immune response against Leishmania major infection. In this study, we performed experiments to evaluate the therapeutic activity of jackfruit KM(+) (jfKM(+)) and its recombinant counterpart (rKM(+)) in experimental paracoccidioidomycosis. To this end, jfKM(+) or rKM(+) was administered to BALB/c mice 10 days after infection with Paracoccidiodes brasiliensis. Thirty days postinfection, lungs from the KM(+)-treated mice contained significantly fewer colony-forming units and little to no organized granulomas compared to the controls. In addition, lung homogenates from the KM(+)-treated mice presented higher levels of nitric oxide, IL-12, interferon-gamma, and tumor necrosis factor-alpha, whereas higher levels of IL-4 and IL-10 were detected in the control group. With mice deficient in IL-12, Toll-like receptor (TLR) 2, TLR4, or TLR adaptor molecule MyD88, we demonstrated that KM(+) led to protection against P. brasiliensis infection through IL-12 production, which was dependent on TLR2. These results demonstrated a beneficial effect of KM(+) on the severity of P. brasiliensis infection and may expand its potential use as a novel immunotherapeutic molecule.
KM(+)是一种来自波罗蜜的甘露糖结合凝集素,可诱导巨噬细胞产生白细胞介素(IL)-12,并引发针对杜氏利什曼原虫感染的保护性辅助性T细胞1免疫反应。在本研究中,我们进行了实验,以评估波罗蜜KM(+)(jfKM(+))及其重组对应物(rKM(+))在实验性副球孢子菌病中的治疗活性。为此,在感染巴西副球孢子菌10天后,将jfKM(+)或rKM(+)给予BALB/c小鼠。感染后30天,与对照组相比,接受KM(+)治疗的小鼠肺部菌落形成单位显著减少,几乎没有或没有组织化肉芽肿。此外,接受KM(+)治疗的小鼠肺匀浆中一氧化氮、IL-12、干扰素-γ和肿瘤坏死因子-α水平较高,而对照组中检测到较高水平的IL-4和IL-10。对于缺乏IL-12、Toll样受体(TLR)2、TLR4或TLR接头分子MyD88的小鼠,我们证明KM(+)通过依赖TLR2产生IL-12来保护小鼠免受巴西副球孢子菌感染。这些结果证明了KM(+)对巴西副球孢子菌感染严重程度的有益作用,并可能扩大其作为新型免疫治疗分子的潜在用途。